|
1
|
Lapointe S, Perry A and Butowski NA:
Primary brain tumours in adults. Lancet. 392:432–446. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang K, Wu Z, Zhang H, Zhang N, Wu W, Wang
Z, Dai Z, Zhang X, Zhang L, Peng Y, et al: Glioma targeted therapy:
Insight into future of molecular approaches. Mol Cancer. 21:392022.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weller M, van den Bent M, Preusser M, Le
Rhun E, Tonn JC, Minniti G, Bendszus M, Balana C, Chinot O, Dirven
L, et al: EANO guidelines on the diagnosis and treatment of diffuse
gliomas of adulthood. Nat Rev Clin Oncol. 18:170–186. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang T, Nam DH, Ram Z, Poon WS, Wang J,
Boldbaatar D, Mao Y, Ma W, Mao Q, You Y, et al: Clinical practice
guidelines for the management of adult diffuse gliomas. Cancer
Lett. 499:60–72. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stupp R, Taillibert S, Kanner A, Read W,
Steinberg D, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K,
et al: Effect of tumor-treating fields plus maintenance
temozolomide vs maintenance temozolomide alone on survival in
patients with glioblastoma: A randomized clinical trial. JAMA.
318:2306–2316. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nicholson JG and Fine HA: Diffuse glioma
heterogeneity and its therapeutic implications. Cancer Discov.
11:575–590. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Przybylowski CJ, Hervey-Jumper SL and
Sanai N: Surgical strategy for insular glioma. J Neurooncol.
151:491–497. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tan AC, Ashley DM, López GY, Malinzak M,
Friedman HS and Khasraw M: Management of glioblastoma: State of the
art and future directions. CA Cancer J Clin. 70:299–312. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yeo AT, Rawal S, Delcuze B, Christofides
A, Atayde A, Strauss L, Balaj L, Rogers VA, Uhlmann EJ, Varma H, et
al: Single-cell RNA sequencing reveals evolution of immune
landscape during glioblastoma progression. Nat Immunol. 23:971–984.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang LB, Karpova A, Gritsenko MA, Kyle JE,
Cao S, Li Y, Rykunov D, Colaprico A, Rothstein JH, Hong R, et al:
Proteogenomic and metabolomic characterization of human
glioblastoma. Cancer Cell. 39:509–528.e20. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bian X, Liu R, Meng Y, Xing D, Xu D and Lu
Z: Lipid metabolism and cancer. J Exp Med. 218:e202016062021.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Martínez-Reyes I and Chandel NS: Cancer
metabolism: Looking forward. Nat Rev Cancer. 21:669–680. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pavlova NN, Zhu J and Thompson CB: The
hallmarks of cancer metabolism: Still emerging. Cell Metab.
34:355–377. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang N, Xie B, Xiao W, Fan M, Xu S, Duan
Y, Hamsafar Y, Evans AC, Huang J, Zhou W, et al: Fatty acid
oxidation fuels glioblastoma radioresistance with CD47-mediated
immune evasion. Nat Commun. 13:15112022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cheng X, Geng F, Pan M, Wu X, Zhong Y,
Wang C, Tian Z, Cheng C, Zhang R, Puduvalli V, et al: Targeting
DGAT1 ameliorates glioblastoma by increasing fat catabolism and
oxidative stress. Cell Metab. 32:229–242.e8. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Martin-Perez M, Urdiroz-Urricelqui U,
Bigas C and Benitah SA: The role of lipids in cancer progression
and metastasis. Cell Metab. 34:1675–1699. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Puca F, Yu F, Bartolacci C, Pettazzoni P,
Carugo A, Huang-Hobbs E, Liu J, Zanca C, Carbone F, Del Poggetto E,
et al: Medium-chain acyl CoA dehydrogenase protects mitochondria
from lipid peroxidation in glioblastoma. Cancer Discov.
11:2904–2923. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bi J and Mischel PS: Acyl-CoA-binding
protein fuels gliomagenesis. Cell Metab. 30:229–230. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao Z, Zhang KN, Wang Q, Li G, Zeng F,
Zhang Y, Wu F, Chai R, Wang Z, Zhang C, et al: Chinese glioma
genome atlas (CGGA): A comprehensive resource with functional
genomic data from Chinese glioma patients. Genomics Proteomics
Bioinformatics. 19:1–12. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liberzon A, Subramanian A, Pinchback R,
Thorvaldsdóttir H, Tamayo P and Mesirov JP: Molecular signatures
database (MSigDB) 3.0. Bioinformatics. 27:1739–1740. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gentleman RC, Carey VJ, Bates DM, Bolstad
B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al:
Bioconductor: Open software development for computational biology
and bioinformatics. Genome Biol. 5:R802004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun D, Wang J, Han Y, Dong X, Ge J, Zheng
R, Shi X, Wang B, Li Z, Ren P, et al: TISCH: A comprehensive web
resource enabling interactive single-cell transcriptome
visualization of tumor microenvironment. Nucleic Acids Res.
49:D1420–D1430. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Canzler S and Hackermüller J: multiGSEA: A
GSEA-based pathway enrichment analysis for multi-omics data. BMC
Bioinformatics. 21:5612020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sotiriou C, Wirapati P, Loi S, Harris A,
Fox S, Smeds J, Nordgren H, Farmer P, Praz V, Haibe-Kains B, et al:
Gene expression profiling in breast cancer: understanding the
molecular basis of histologic grade to improve prognosis. J Natl
Cancer Inst. 98:262–272. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Laska E, Meisner M and Wanderling J: A
maximally selected test of symmetry about zero. Stat Med.
31:3178–3191. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim JC, Heo YJ, Kang SY, Lee J and Kim KM:
Validation of the combined biomarker for prediction of response to
checkpoint inhibitor in patients with advanced cancer. Cancers
(Basel). 13:23162021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang X, Shi M, Chen T and Zhang B:
Characterization of the immune cell infiltration landscape in head
and neck squamous cell carcinoma to aid immunotherapy. Mol Ther
Nucleic Acids. 22:298–309. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tu B, Ye L, Cao Q, Gong S, Jiang M and Li
H: Identification of a five-miRNA signature as a novel potential
prognostic biomarker in patients with nasopharyngeal carcinoma.
Hereditas. 159:32022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jung H, Kim HS, Kim JY, Sun JM, Ahn JS,
Ahn MJ, Park K, Esteller M, Lee SH and Choi JK: DNA methylation
loss promotes immune evasion of tumours with high mutation and copy
number load. Nat Commun. 10:42782019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Baty F, Joerger M, Früh M, Klingbiel D,
Zappa F and Brutsche M: 24 h-gene variation effect of combined
bevacizumab/erlotinib in advanced non-squamous non-small cell lung
cancer using exon array blood profiling. J Transl Med. 15:662017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Clough E and Barrett T: The gene
expression omnibus database. Methods Mol Biol. 1418:93–110. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Braun DA, Hou Y, Bakouny Z, Ficial M,
Sant' Angelo M, Forman J, Ross-Macdonald P, Berger AC, Jegede OA,
Elagina L, et al: Interplay of somatic alterations and immune
infiltration modulates response to PD-1 blockade in advanced clear
cell renal cell carcinoma. Nat Med. 26:909–918. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu R, Liang W, Hua Q, Wu L, Wang X, Li Q,
Zhong F, Li B and Qiu Z: Fatty acid metabolic signaling pathway
alternation predict prognosis of immune checkpoint inhibitors in
glioblastoma. Front Immunol. 13:8195152022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lin H, Patel S, Affleck VS, Wilson I,
Turnbull DM, Joshi AR, Maxwell R and Stoll EA: Fatty acid oxidation
is required for the respiration and proliferation of malignant
glioma cells. Neuro Oncol. 19:43–54. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Otasek D, Morris JH, Bouças J, Pico AR and
Demchak B: Cytoscape automation: Empowering workflow-based network
analysis. Genome Biol. 20:1852019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu H, Zhang Y, Liu J, Cui J, Gan Y, Wu Z,
Chang Y, Sui R, Chen Y, Shi J, et al: UM-164, a dual inhibitor of
c-Src and p38 MAPK, suppresses proliferation of glioma by reducing
YAP activity. Cancers (Basel). 14:53432022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Luis G, Godfroid A, Nishiumi S, Cimino J,
Blacher S, Maquoi E, Wery C, Collignon A, Longuespée R,
Montero-Ruiz L, et al: Tumor resistance to ferroptosis driven by
Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and fatty acid
biding protein-4 (FABP4) in tumor microenvironment promote tumor
recurrence. Redox Biol. 43:1020062021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wu L, Zhang X, Zheng L, Zhao H, Yan G,
Zhang Q, Zhou Y, Lei J, Zhang J, Wang J, et al: RIPK3 orchestrates
fatty acid metabolism in tumor-associated macrophages and
hepatocarcinogenesis. Cancer Immunol Res. 8:710–721. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ma Y, Temkin SM, Hawkridge AM, Guo C, Wang
W, Wang XY and Fang X: Fatty acid oxidation: An emerging facet of
metabolic transformation in cancer. Cancer Lett. 435:92–100. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Juraszek B, Czarnecka-Herok J and Nałęcz
KA: Glioma cells survival depends both on fatty acid oxidation and
on functional carnitine transport by SLC22A5. J Neurochem.
156:642–657. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Strickland M and Stoll EA: Metabolic
reprogramming in glioma. Front Cell Dev Biol. 5:432017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Miska J, Lee-Chang C, Rashidi A, Muroski
ME, Chang AL, Lopez-Rosas A, Zhang P, Panek WK, Cordero A, Han Y,
et al: HIF-1α is a metabolic switch between glycolytic-driven
migration and oxidative phosphorylation-driven immunosuppression of
Tregs in glioblastoma. Cell Rep. 27:226–237.e4. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhao F, Xiao C, Evans KS, Theivanthiran T,
DeVito N, Holtzhausen A, Liu J, Liu X, Boczkowski D, Nair S, et al:
Paracrine Wnt5a-β-catenin signaling triggers a metabolic program
that drives dendritic cell tolerization. Immunity. 48:147–160.e7.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pearce EL, Walsh MC, Cejas PJ, Harms GM,
Shen H, Wang LS, Jones RG and Choi Y: Enhancing CD8 T-cell memory
by modulating fatty acid metabolism. Nature. 460:103–107. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang T, Fahrmann JF, Lee H, Li YJ,
Tripathi SC, Yue C, Zhang C, Lifshitz V, Song J, Yuan Y, et al:
JAK/STAT3-regulated fatty acid β-oxidation is critical for breast
cancer stem cell self-renewal and chemoresistance. Cell Metab.
27:136–150.e5. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhan Y, Qiao W, Yi B, Yang X, Li M, Sun L,
Ji L, Su P, Wang X, Zhang F, et al: Dual role of pseudogene
TMEM198B in promoting lipid metabolism and immune escape of glioma
cells. Oncogene. 41:4512–4523. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Song G, Xu S, Zhang H, Wang Y, Xiao C,
Jiang T, Wu L, Zhang T, Sun X, Zhong L, et al: TIMP1 is a
prognostic marker for the progression and metastasis of colon
cancer through FAK-PI3K/AKT and MAPK pathway. J Exp Clin Cancer
Res. 35:1482016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yi YC, Chen MK, Chen LY, Ho ES, Ying TH,
Wang PH and Yang SF: Genetic polymorphism of the tissue inhibitor
of metalloproteinase-1 is associated with an increased risk of
endometrial cancer. Clin Chim Acta. 409:127–131. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Eiro N, González L, Martínez-Ordoñez A,
Fernandez-Garcia B, González LO, Cid S, Dominguez F,
Perez-Fernandez R and Vizoso FJ: Cancer-associated fibroblasts
affect breast cancer cell gene expression, invasion and
angiogenesis. Cell Oncol (Dordr). 41:369–378. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Tian Z, Ou G, Su M, Li R, Pan L, Lin X,
Zou J, Chen S, Li Y, Huang K and Chen Y: TIMP1 derived from
pancreatic cancer cells stimulates schwann cells and promotes the
occurrence of perineural invasion. Cancer Lett. 546:2158632022.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang L, Jiang Q, Li DZ, Zhou X, Yu DS and
Zhong J: TIMP1 mRNA in tumor-educated platelets is diagnostic
biomarker for colorectal cancer. Aging (Albany NY). 11:8998–9012.
2019. View Article : Google Scholar : PubMed/NCBI
|
